novo nordisk cuts prices for its glp-1 drugs. Obesity Drugs Yes, you heard that right

EXAMINE showed a slight, but non-significant decrease in HF related hospitalization, while SAVOR-TIMI53 showed an increase in HF hospitalization with DPP-4i use

Act 4: The Grand Appetite Suppression Finale For the grand finale, we have the uproarious appetite suppression showstopper

Safety and Side Effects Like all GLP-1 medications, both liraglutide and semaglutide can cause some gastrointestinal distress including nausea, diarrhea, vomiting, reflux and constipation

After decades of research and development, scientists have created next-generation GLP-1 drugs with applications that extend far beyond the treatment of type 2 diabetes

The degree of systolic blood pressure (SBP) reduction varies across studies

Additionally, most mechanistic studies rely on animal models, raising concerns about translatability to humans due to interspecies differences in GLP-1R distribution and signaling (Drucker, 2022)